Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation

Blood

Volumn 124, Issue 7, 2014, Pages 1119-1126

  Hervier, Baptiste ^a,b,c   Haroche, Julien ^a,b,c   Arnaud, Laurent ^a,b,c   Charlotte, Frédéric ^a,b   Donadieu, Jean ^d   Néel, Antoine ^e   Lifermann, François ^f   Villabona, Carles ^g   Graffin, Bruno ^h   Hermine, Olivier ⁱ   Rigolet, Aude ^a,b   Roubille, Camille ^j   Hachulla, Eric ^k   Carmoi, Thierry ^l   Bézier, Maud ^m   Meignin, Véronique ^m   Conrad, Marie ⁿ   Marie, Laurence ^o   Kostrzewa, Elise ^p   Michot, Jean Marie ^q   Barete, Stéphane ^r   Taly, Valerie ^s   Cury, Karine ^r   Emile, Jean François ^t,u   Amoura, Zahir ^a,b,c   more..

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSERM   (France)

^d ARMAND TROUSSEAU HOSPITAL   (France)

^e HÔTEL DIEU   (France)

^f HÔPITAL DU BOCAGE   (France)

^g HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^h Department of Dermatology   (France)

ⁱ HÔPITAL NECKER ENFANTS MALADES   (France)

^j HÔPITAL SAINT ELOI   (France)

^k LILLE UNIVERSITY HOSPITAL   (France)

^l University of Paris Descartes   (France)

^m SAINT LOUIS HOSPITAL   (France)

ⁿ UNIVERSITY HOSPITAL OF NANCY   (France)

^o Groupe Hospitalier Intercommunal Le Raincy Montfermeil   (France)

^p BORDEAUX UNIVERSITY HOSPITAL   (France)

^q BICÊTRE HOSPITAL   (France)

^r HÔPITAL TENON   (France)

^s Severe aplastic anaemia working party of the European blood and marrow transplantation group   (France)

^t HÔPITAL AMBROISE PARÉ   (France)

^u LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; B RAF KINASE; CLADRIBINE; ETOPOSIDE; METHOTREXATE; RETINOIC ACID; STEROID; VINBLASTINE; BRAF PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOPSY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ERDHEIM CHESTER DISEASE; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; LANGERHANS CELL HISTIOCYTOSIS; MALE; MULTICENTER STUDY; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT RESPONSE; ERDHEIM-CHESTER DISEASE; GENETIC PREDISPOSITION; GENETICS; HISTIOCYTOSIS, LANGERHANS-CELL; KAPLAN MEIER METHOD; MIDDLE AGED; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; PRESCHOOL CHILD; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; ERDHEIM-CHESTER DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MUTATION, MISSENSE; PROTO-ONCOGENE PROTEINS B-RAF; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84905992289     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-12-543793     Document Type: Article

References (50)

1. Arnaud L, Gorochov G, Charlotte F, et al. Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patients. Blood. 2011;117(10):2783-2790.
2. Badalian-Very G, Vergilio JA, Degar BA, et al. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010;116(11):1919-1923.
3. Badalian-Very G, Vergilio JA, Fleming M, Rollins BJ. Pathogenesis of Langerhans cell histiocytosis. Annu Rev Pathol. 2013;8:1-20.
4. Berres ML, Allen CE, Merad M. Pathological consequence of misguided dendritic cell differentiation in histiocytic diseases. Adv Immunol. 2013;120:127-161.
5. Arnaud L, Hervier B, Néel A, et al. CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients. Blood. 2011;117(10):2778-2782.
6. Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol. 1990;7(1):19-73. (Pubitemid 20075700)
7. Haroche J, Arnaud L, Cohen-Aubart F, et al. Erdheim-Chester disease. Rheum Dis Clin North Am. 2013;39(2):299-311.
8. Dion E, Graef C, Miquel A, et al. Bone involvement in Erdheim-Chester disease: imaging findings including periostitis and partial epiphyseal involvement. Radiology. 2006;238(2):632-639. (Pubitemid 43134376)
9. Haroche J, Cluzel P, Toledano D, et al. Images in cardiovascular medicine. Cardiac involvement in Erdheim-Chester disease: magnetic resonance and computed tomographic scan imaging in a monocentric series of 37 patients. Circulation. 2009;119(25):e597-e598.
10. Haroche J, Amoura Z, Dion E, et al. Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: report of 6 new cases and a literature review. Medicine (Baltimore). 2004;83(6):371-392. (Pubitemid 39541113)
11. Serratrice J, Granel B, De Roux C, et al. "Coated aorta": a new sign of Erdheim-Chester disease. J Rheumatol. 2000;27(6):1550-1553. (Pubitemid 30354063)
12. Haroche J, Charlotte F, Arnaud L, et al. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood. 2012;120(13):2700-2703.
13. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 9-2000. A 41-year-old man with multiple bony lesions and adjacent soft-tissue masses. N Engl J Med. 2000;342(12):875-883.
14. Adle-Biassette H, Chetritt J, Bergemer-Fouquet AM, Wechsler J, Mussini JM, Gray F. Pathology of the central nervous system in Chester-Erdheim disease: report of three cases. J Neuropathol Exp Neurol. 1997;56(11):1207-1216. (Pubitemid 27492777)
15. Andrade VP, Nemer CC, Prezotti AN, Goulart WS. Erdheim-Chester disease of the breast associated with Langerhans-cell histiocytosis of the hard palate. Virchows Arch. 2004;445(4):405-409. (Pubitemid 39517767)
16. Aouba A, Larousserie F, Le Guern V, Martin A, Guillevin L. Spumous histiocytic oligoarthritis coexisting with systemic Langerhans' cell histiocytosis: case report and literature review. Joint Bone Spine. 2009;76(6):701-704.
17. Bisceglia M, Cammisa M, Suster S, Colby TV. Erdheim-Chester disease: clinical and pathologic spectrum of four cases from the Arkadi M. Rywlin slide seminars. Adv Anat Pathol. 2003;10(3):160-171.
18. Brower AC, Worsham GF, Dudley AH. Erdheim-Chester disease: a distinct lipoidosis or part of the spectrum of histiocytosis? Radiology. 1984;151(1):35-38. (Pubitemid 14165346)
19. Furmanczyk PS, Bruckner JD, Gillespy T III, Rubin BP. An unusual case of Erdheim-Chester disease with features of Langerhans cell histiocytosis. Skeletal Radiol. 2007;36(9):885-889. (Pubitemid 47278641)
20. Granier M, Micheau A, Serre I. A rare cause of cardiac tumour: an Erdheim-Chester disease with cardiac involvement co-existing with an intracerebral Langerhans cell histiocytosis. Eur Heart J. 2008;29(16):1929.
21. Kambouchner M, Colby TV, Domenge C, Battesti JP, Soler P, Tazi A. Erdheim-Chester disease with prominent pulmonary involvement associated with eosinophilic granuloma of mandibular bone. Histopathology. 1997;30(4):353-358. (Pubitemid 27168796)
22. Kerzl R, Eyerich K, Eberlein B, et al. Parallel occurrence of Erdheim-Chester disease and eosinophilic granuloma in the same patient. J Eur Acad Dermatol Venereol. 2009;23(2):224-226.
23. Naruse H, Shoda H, Okamoto A, Oka T, Yamamoto K. A case of osteoarthropathy due to Erdheim-Chester disease with overlapping Langerhans' cell infiltration. Intern Med. 2010;49(12):1225-1228.
24. Pineles SL, Liu GT, Acebes X, et al. Presence of Erdheim-Chester disease and Langerhans cell histiocytosis in the same patient: a report of 2 cases. J Neuroophthalmol. 2011;31(3):217-223.
25. Tsai JW, Tsou JH, Hung LY, Wu HB, Chang KC. Combined Erdheim-Chester disease and Langerhans cell histiocytosis of skin are both monoclonal: a rare case with human androgen-receptor gene analysis. J Am Acad Dermatol. 2010;63(2):284-291.
26. Vital C, Bioulac-Sage P, Tison F, et al. Brain stem infiltration by mixed Langerhans cell histiocytosis and Chester-Erdheim disease: more than just an isolated case? Clin Exp Pathol. 1999;47(2):71-76. (Pubitemid 29268866)
27. Yin J, Zhang F, Zhang H, et al. Hand-Schüller-Christian disease and Erdheim-Chester disease: coexistence and discrepancy. Oncologist. 2013;18(1):19-24.
28. Arnaud L, Malek Z, Archambaud F, et al. 18F-fluorodeoxyglucose-positron emission tomography scanning is more useful in follow-up than in the initial assessment of patients with Erdheim-Chester disease. Arthritis Rheum. 2009;60(10):3128-3138.
29. Arnaud L, Pierre I, Beigelman-Aubry C, et al. Pulmonary involvement in Erdheim-Chester disease: a single-center study of thirty-four patients and a review of the literature. Arthritis Rheum. 2010;62(11):3504-3512.
30. Haroche J, Amoura Z, Touraine P, et al. Bilateral adrenal infiltration in Erdheim-Chester disease. Report of seven cases and literature review. J Clin Endocrinol Metab. 2007;92(6):2007-2012. (Pubitemid 46997091)
31. Brun AL, Touitou-Gottenberg D, Haroche J, et al. Erdheim-Chester disease: CT findings of thoracic involvement. Eur Radiol. 2010;20(11):2579-2587.
32. Tirkes T, Hollar MA, Tann M, Kohli MD, Akisik F, Sandrasegaran K. Response criteria in oncologic imaging: review of traditional and new criteria. Radiographics. 2013;33(5):1323-1341.
33. Tiacci E, Trifonov V, Schiavoni G, et al. BRAF mutations in hairy-cell leukemia. N Engl J Med. 2011;364(24):2305-2315.
34. Taly V, Pekin D, Benhaim L, et al. Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients. Clin Chem. 2013;59(12):1722-1731.
35. Conrad M, Haroche J, Charlotte F, et al. A 75-year-old woman admitted to the ICU with respiratory failure. Chest. 2012;142(4):1063-1067.
36. Lachenal F, Cotton F, Desmurs-Clavel H, et al. Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: report of 6 cases and systematic review of the literature. J Neurol. 2006;253(10):1267-1277. (Pubitemid 44691550)
37. A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993. The French Langerhans' Cell Histiocytosis Study Group. Arch Dis Child. 1996;75(1):17-24.
38. Aricò M, Girschikofsky M, Généreau T, et al Report from the International Registry of the Histiocyte Society. Langerhans cell histiocytosis in adults. Eur J Cancer. 2003;39(16):2341-2348.
39. Allen TC. Pulmonary Langerhans cell histiocytosis and other pulmonary histiocytic diseases: a review. Arch Pathol Lab Med. 2008;132(7):1171-1181. (Pubitemid 351955744)
40. Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol. 2009;27:669-692.
41. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science. 2010;327(5966):656-661.
42. Hirose M. Improvement of Langerhans' cell histiocytosis and pancreatitis by alpha-interferon. Med Pediatr Oncol. 1997;28(6):462-463. (Pubitemid 27208559)
43. Culić S, Jakobson A, Culić V, Kuzmić I, Sćukanec-Spoljar M, Primorac D. Etoposide as the basic and interferon-alpha as the maintenance therapy for Langerhans cell histiocytosis: a RTC. Pediatr Hematol Oncol. 2001;18(4):291-294.
44. Chang SE, Koh GJ, Choi JH, et al. Widespread skin-limited adult Langerhans cell histiocytosis: long-term follow-up with good response to interferon alpha. Clin Exp Dermatol. 2002;27(2):135-137. (Pubitemid 35024869)
45. Kwong YL, Chan AC, Chan TK. Widespread skin-limited Langerhans cell histiocytosis: complete remission with interferon alfa. J Am Acad Dermatol. 1997;36(4):628-629. (Pubitemid 27164498)
46. Braiteh F, Boxrud C, Esmaeli B, Kurzrock R. Successful treatment of Erdheim-Chester disease, a non-Langerhans-cell histiocytosis, with interferon-alpha. Blood. 2005;106(9):2992-2994. (Pubitemid 41565890)
47. Haroche J, Amoura Z, Trad SG, et al. Variability in the efficacy of interferon-alpha in Erdheim-Chester disease by patient and site of involvement: results in eight patients. Arthritis Rheum. 2006;54(10):3330-3336. (Pubitemid 44622105)
48. Hervier B, Arnaud L, Charlotte F, et al. Treatment of Erdheim-Chester disease with long-term high-dose interferon-α. Semin Arthritis Rheum. 2012;41(6):907-913.
49. Haroche J, Cohen-Aubart F, Emile JF, et al. Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation. Blood. 2013;121(9):1495-1500.
50. Heaney ML. Saving orphans: BRAF targeting of histiocytosis. Blood. 2013;121(9):1487-1488.